Toll Free: 1-888-928-9744
Published: Apr, 2017 | Pages:
105 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report studies the global Type 2 Diabetes Mellitus Therapeutics market, analyzes and researches the Type 2 Diabetes Mellitus Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • AstraZeneca • Novartis • Novo Nordisk • Boehringer Ingelheim • Bristol-Myers Squibb • Eli Lilly • Merck • Sanofi • Salix Pharmaceuticals • Takeda Pharmaceutical Company Limited • Ji'Nan Orgachem Pharmaceutical Co., Ltd. • Shihuida PHARMA Group • Henan Tian Fang Pharmaceutical Co., Ltd. • Disha Pharmaceutical Group Market segment by Regions/Countries, this report covers • United States • EU • Japan • China • India • Southeast Asia Market segment by Type, Type 2 Diabetes Mellitus Therapeutics can be split into • Biguanides • Insulin • Thiazolidinediones • Insulin Secretagogues • Others Market segment by Application, Type 2 Diabetes Mellitus Therapeutics can be split into • Hospital • Clinic • Other If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Type 2 Diabetes Mellitus Therapeutics Market Size, Status and Forecast 2022 1 Industry Overview of Type 2 Diabetes Mellitus Therapeutics 1.1 Type 2 Diabetes Mellitus Therapeutics Market Overview 1.1.1 Type 2 Diabetes Mellitus Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Type 2 Diabetes Mellitus Therapeutics Market by Type 1.3.1 Biguanides 1.3.2 Insulin 1.3.3 Thiazolidinediones 1.3.4 Insulin Secretagogues 1.3.5 Others 1.4 Type 2 Diabetes Mellitus Therapeutics Market by End Users/Application 1.4.1 Hospital 1.4.2 Clinic 1.4.3 Other 2 Global Type 2 Diabetes Mellitus Therapeutics Competition Analysis by Players 2.1 Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 AstraZeneca 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Novo Nordisk 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Boehringer Ingelheim 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Bristol-Myers Squibb 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Eli Lilly 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Merck 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Sanofi 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Salix Pharmaceuticals 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Takeda Pharmaceutical Company Limited 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Type 2 Diabetes Mellitus Therapeutics Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Ji'Nan Orgachem Pharmaceutical Co., Ltd. 3.12 Shihuida PHARMA Group 3.13 Henan Tian Fang Pharmaceutical Co., Ltd. 3.14 Disha Pharmaceutical Group 4 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Type and Application (2012-2017) 4.1 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Type (2012-2017) 4.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Application (2012-2017) 4.3 Potential Application of Type 2 Diabetes Mellitus Therapeutics in Future 4.4 Top Consumer/End Users of Type 2 Diabetes Mellitus Therapeutics 5 United States Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 5.1 United States Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 5.2 United States Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 6 EU Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 6.1 EU Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 6.2 EU Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 7 Japan Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 7.1 Japan Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 7.2 Japan Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 8 China Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 8.1 China Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 8.2 China Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 9 India Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 9.1 India Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 9.2 India Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 10 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Development Status and Outlook 10.1 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (2012-2017) 10.2 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size and Market Share by Players (2016 and 2017) 11 Market Forecast by Regions, Type and Application (2017-2022) 11.1 Global Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Regions (2017-2022) 11.1.1 United States Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.1.2 EU Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.1.3 Japan Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.1.4 China Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.1.5 India Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.1.6 Southeast Asia Type 2 Diabetes Mellitus Therapeutics Revenue and Growth Rate (2017-2022) 11.2 Global Type 2 Diabetes Mellitus Therapeutics Market Size (Value) by Type (2017-2022) 11.3 Global Type 2 Diabetes Mellitus Therapeutics Market Size by Application (2017-2022) 12 Type 2 Diabetes Mellitus Therapeutics Market Dynamics 12.1 Type 2 Diabetes Mellitus Therapeutics Market Opportunities 12.2 Type 2 Diabetes Mellitus Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Type 2 Diabetes Mellitus Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Type 2 Diabetes Mellitus Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Type 2 Diabetes Mellitus Therapeutics Product Scope Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) (2012-2017) Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Regions in 2016 Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Type in 2016 Figure Biguanides Market Size (Million USD) and Growth Rate (2012-2017) Figure Insulin Market Size (Million USD) and Growth Rate (2012-2017) Figure Thiazolidinediones Market Size (Million USD) and Growth Rate (2012-2017) Figure Insulin Secretagogues Market Size (Million USD) and Growth Rate (2012-2017) Figure Others Market Size (Million USD) and Growth Rate (2012-2017) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Share by Application in 2016 Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2012-2017) Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2012-2017) Figure Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017) Table Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2016 and 2017) Figure Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Table AstraZeneca Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017) Figure AstraZeneca Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Novartis Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Novartis (2012-2017) Figure Novartis Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Novo Nordisk Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Novo Nordisk (2012-2017) Figure Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Boehringer Ingelheim Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017) Figure Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Bristol-Myers Squibb Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017) Figure Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Eli Lilly Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Eli Lilly (2012-2017) Figure Eli Lilly Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Merck Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Merck (2012-2017) Figure Merck Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Sanofi Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017) Figure Sanofi Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Salix Pharmaceuticals Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Salix Pharmaceuticals (2012-2017) Figure Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Takeda Pharmaceutical Company Limited Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical Company Limited (2012-2017) Figure Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Ji'Nan Orgachem Pharmaceutical Co., Ltd. Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Ji'Nan Orgachem Pharmaceutical Co., Ltd. (2012-2017) Figure Ji'Nan Orgachem Pharmaceutical Co., Ltd. Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Shihuida PHARMA Group Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Shihuida PHARMA Group (2012-2017) Figure Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Henan Tian Fang Pharmaceutical Co., Ltd. Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Henan Tian Fang Pharmaceutical Co., Ltd. (2012-2017) Figure Henan Tian Fang Pharmaceutical Co., Ltd. Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Disha Pharmaceutical Group Basic Information List Table Type 2 Diabetes Mellitus Therapeutics Business Revenue (Million USD) of Disha Pharmaceutical Group (2012-2017) Figure Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Business Revenue Market Share in 2016 Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Type (2012-2017) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2012 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2013 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2014 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2015 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2016 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2017 Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application (2012-2017) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2012 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2013 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2014 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2016 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2017 Table Top Consumer/End Users of Type 2 Diabetes Mellitus Therapeutics Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table United States Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure United States Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table EU Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure EU Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Japan Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure Japan Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table China Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure China Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure China Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table India Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure India Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure India Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Players (2012-2017) Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2016 Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Market Size Share by Players in 2017 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Regions (2017-2022) Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Regions (2017-2022) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Regions in 2017 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Regions in 2022 Figure United States Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Figure EU Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Figure Japan Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Figure China Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Figure India Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Figure Southeast Asia Type 2 Diabetes Mellitus Therapeutics Revenue (Million USD) and Growth Rate (2017-2022) Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Type (2017-2022) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2017 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size Share by Type in 2022 Table Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application (2017-2022) Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2017 Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.